These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26598593)

  • 1. The Accompanying Changes in Brain Structure of a Remitted Depression Patient with the Bupropion Treatment.
    Hou YC; Lai CH
    Clin Psychopharmacol Neurosci; 2015 Dec; 13(3):319-20. PubMed ID: 26598593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of bupropion's mechanism of antidepressant activity.
    Ferris RM; Cooper BR; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):74-8. PubMed ID: 6406468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rapid tryptophan depletion on sleep electroencephalogram and mood in subjects with partially remitted depression on bupropion.
    Evans L; Golshan S; Kelsoe J; Rapaport M; Resovsky K; Sutton L; Gillin JC
    Neuropsychopharmacology; 2002 Dec; 27(6):1016-26. PubMed ID: 12464458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.
    Cooper BR; Hester TJ; Maxwell RA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):127-34. PubMed ID: 6778989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.
    El Mansari M; Ghanbari R; Janssen S; Blier P
    Neuropharmacology; 2008 Dec; 55(7):1191-8. PubMed ID: 18708076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bupropion augmentation of minocycline in the treatment of depression.
    Bendale M; DSouza SR; Addepalli V; Kale PP
    Acta Neurobiol Exp (Wars); 2019; 79(2):217-224. PubMed ID: 31342957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
    Ferris RM; Beaman OJ
    Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of bupropion on hybrid striped bass brain chemistry and predatory behavior.
    Sweet LE; Bisesi JH; Lei EN; Lam MH; Klaine SJ
    Environ Toxicol Chem; 2016 Aug; 35(8):2058-65. PubMed ID: 26748934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion in depression. I. Biochemical effects and clinical response.
    Golden RN; Rudorfer MV; Sherer MA; Linnoila M; Potter WZ
    Arch Gen Psychiatry; 1988 Feb; 45(2):139-43. PubMed ID: 3122698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-Like Effect of the Norepinephrine-Dopamine Reuptake Inhibitor Bupropion in a Mouse Model of Huntington's Disease with Dopaminergic Dysfunction.
    Renoir T; Argyropoulos A; Hannan AJ
    J Huntingtons Dis; 2012; 1(2):261-6. PubMed ID: 25063334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion: new therapy for depression.
    Feinberg M
    Am Fam Physician; 1990 Jun; 41(6):1787-90. PubMed ID: 2112333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice.
    Kale PP; Addepalli V
    Pharmacol Biochem Behav; 2014 Sep; 124():238-44. PubMed ID: 24933334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute psychosis following sustained release bupropion overdose.
    Wang TS; Shiah IS; Yeh CB; Chang CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):149-51. PubMed ID: 15610958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment.
    Dong J; Blier P
    Psychopharmacology (Berl); 2001 Apr; 155(1):52-7. PubMed ID: 11374336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion for depression in schizophrenia.
    Englisch S; Inta D; Eer A; Zink M
    Clin Neuropharmacol; 2010; 33(5):257-9. PubMed ID: 20852411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex.
    Hudson AL; Lalies MD; Silverstone P
    Can J Physiol Pharmacol; 2012 Jun; 90(6):803-9. PubMed ID: 22512539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion Hydrochloride.
    Khan SR; Berendt RT; Ellison CD; Ciavarella AB; Asafu-Adjaye E; Khan MA; Faustino PJ
    Profiles Drug Subst Excip Relat Methodol; 2016; 41():1-30. PubMed ID: 26940167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.